FDA Pioneers Sunscreen Revolution with New Ingredient Approval

The U.S. FDA has introduced bemotrizinol as a new active ingredient in over-the-counter sunscreens, marking the first such approval since the 1990s. This addition enhances UV protection with minimal skin absorption. The move is part of broader efforts to improve sun safety and public health protection.

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol as a new active ingredient in over-the-counter sunscreens, the first such addition since the late 1990s. This move aims to enhance sun protection standards by offering improved defense against both ultraviolet A and B rays, with low absorption levels into the skin.

Bemotrizinol, already available in Europe and other markets, is recognized for its superior stability and efficacy as a UV filter. The FDA highlights its minimal absorption into the body, addressing consumer and regulatory concerns about chemical sunscreens penetrating the skin.

This approval is part of ongoing efforts by health authorities to broaden and improve the spectrum of sun protection available to the public, ensuring better health safety measures against harmful UV exposure.